Terms: = Germ cell tumor AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Prognosis
20 results:
1. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
[TBL] [Abstract] [Full Text] [Related]
2. [Prognostic significance of invasion in glioblastoma].
Szivós L; Virga J; Hortobágyi T; Zahuczky G; Uray I; Jenei A; Bognár L; Árkosy P; Klekner Á
Ideggyogy Sz; 2020 Sep; 73(9-10):317-325. PubMed ID: 33035418
[TBL] [Abstract] [Full Text] [Related]
3. Delivery luteolin with folacin-modified nanoparticle for glioma therapy.
Wu C; Xu Q; Chen X; Liu J
Int J Nanomedicine; 2019; 14():7515-7531. PubMed ID: 31571861
[TBL] [Abstract] [Full Text] [Related]
4. Screening prognosis-related genes in glioblastoma by microarray analysis.
Wang H; Zhang Y; Zhang C; Tong X
Anticancer Drugs; 2020 Feb; 31(2):150-157. PubMed ID: 31567312
[TBL] [Abstract] [Full Text] [Related]
5. Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.
Monteiro AC; Muenzner JK; Andrade F; Rius FE; Ostalecki C; Geppert CI; Agaimy A; Hartmann A; Fujita A; Schneider-Stock R; Jasiulionis MG
Mol Oncol; 2019 Jun; 13(6):1433-1449. PubMed ID: 31069961
[TBL] [Abstract] [Full Text] [Related]
6. Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray (ngTMA) automated analysis.
Seyed Jafari SM; Wiedmer C; Cazzaniga S; Frangež Ž; Shafighi M; Beltraminelli H; Weber B; Simon HU; Hunger RE
PLoS One; 2018; 13(11):e0207019. PubMed ID: 30408085
[TBL] [Abstract] [Full Text] [Related]
7. Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.
Berardi R; Torniai M; Partelli S; Rubini C; Pagliaretta S; Savini A; Polenta V; Santoni M; Giampieri R; Onorati S; Barucca F; Murrone A; Bianchi F; Falconi M
PLoS One; 2018; 13(5):e0197035. PubMed ID: 29787601
[TBL] [Abstract] [Full Text] [Related]
8. The Driver Mutational Landscape of Ovarian Squamous cell Carcinomas Arising in Mature Cystic Teratoma.
Cooke SL; Ennis D; Evers L; Dowson S; Chan MY; Paul J; Hirschowitz L; Glasspool RM; Singh N; Bell S; Day E; Kochman A; Wilkinson N; Beer P; Martin S; Millan D; Biankin AV; McNeish IA;
Clin Cancer Res; 2017 Dec; 23(24):7633-7640. PubMed ID: 28954785
[No Abstract] [Full Text] [Related]
9. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.
Olmeda D; Cerezo-Wallis D; Riveiro-Falkenbach E; Pennacchi PC; Contreras-Alcalde M; Ibarz N; Cifdaloz M; Catena X; Calvo TG; Cañón E; Alonso-Curbelo D; Suarez J; Osterloh L; Graña O; Mulero F; Megías D; Cañamero M; Martínez-Torrecuadrada JL; Mondal C; Di Martino J; Lora D; Martinez-Corral I; Bravo-Cordero JJ; Muñoz J; Puig S; Ortiz-Romero P; Rodriguez-Peralto JL; Ortega S; Soengas MS
Nature; 2017 Jun; 546(7660):676-680. PubMed ID: 28658220
[TBL] [Abstract] [Full Text] [Related]
10. Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma.
Ramachandran R; Junnuthula VR; Gowd GS; Ashokan A; Thomas J; Peethambaran R; Thomas A; Unni AK; Panikar D; Nair SV; Koyakutty M
Sci Rep; 2017 Mar; 7():43271. PubMed ID: 28262735
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy of lenvatinib in treating thyroid cancer.
Krajewska J; Kukulska A; Jarzab B
Expert Opin Pharmacother; 2016 Aug; 17(12):1683-91. PubMed ID: 27398740
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes of children with central nervous system germinoma treated with multi-agent chemotherapy followed by reduced radiation.
Cheng S; Kilday JP; Laperriere N; Janzen L; Drake J; Bouffet E; Bartels U
J Neurooncol; 2016 Mar; 127(1):173-80. PubMed ID: 26744133
[TBL] [Abstract] [Full Text] [Related]
13. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas.
Ballester LY; Wang Z; Shandilya S; Miettinen M; Burger PC; Eberhart CG; Rodriguez FJ; Raabe E; Nazarian J; Warren K; Quezado MM
Am J Surg Pathol; 2013 Sep; 37(9):1357-64. PubMed ID: 24076776
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor-D.
Kashima K; Watanabe M; Satoh Y; Hata J; Ishii N; Aoki Y
Cancer Sci; 2012 Dec; 103(12):2144-52. PubMed ID: 22937829
[TBL] [Abstract] [Full Text] [Related]
15. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract] [Full Text] [Related]
16. Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome.
Mouawad R; Spano JP; Comperat E; Capron F; Khayat D
Eur J Cancer; 2009 May; 45(8):1407-14. PubMed ID: 19157860
[TBL] [Abstract] [Full Text] [Related]
17. The role of podoplanin in tumor progression and metastasis.
Raica M; Cimpean AM; Ribatti D
Anticancer Res; 2008; 28(5B):2997-3006. PubMed ID: 19031946
[TBL] [Abstract] [Full Text] [Related]
18. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract] [Full Text] [Related]
19. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas.
Jenny B; Harrison JA; Baetens D; Tille JC; Burkhardt K; Mottaz H; Kiss JZ; Dietrich PY; De Tribolet N; Pizzolato GP; Pepper MS
J Pathol; 2006 May; 209(1):34-43. PubMed ID: 16523449
[TBL] [Abstract] [Full Text] [Related]
20. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.
Straume O; Akslen LA
Am J Pathol; 2002 Mar; 160(3):1009-19. PubMed ID: 11891198
[TBL] [Abstract] [Full Text] [Related]
